Final Royalty Report. Upon termination or expiration of this Agreement, Licensee shall submit a final report to TSRI, and any payments due TSRI and unreimbursed patent expenses invoiced by TSRI shall become immediately payable.
Appears in 15 contracts
Samples: License Agreement (Ambrx Biopharma Inc.), License Agreement (Ambrx Biopharma Inc.), License Agreement (Fate Therapeutics Inc)
Final Royalty Report. Upon termination or expiration of this Agreement, Licensee shall promptly submit a final report to TSRI, and any payments due to TSRI and unreimbursed patent expenses invoiced under this Agreement that accrued prior to such termination or expiration shall be paid by Licensee to TSRI shall become immediately payableat the time of delivery of the final report.
Appears in 5 contracts
Samples: License Agreement (Neumora Therapeutics, Inc.), License Agreement (Neumora Therapeutics, Inc.), License Agreement (Neumora Therapeutics, Inc.)
Final Royalty Report. Upon termination or expiration of this Agreement, Licensee shall submit a final report to TSRI, and any payments due TSRI and unreimbursed patent fees and expenses invoiced by TSRI incurred prior to such expiration or termination shall become immediately payablepayable to TSRI.
Appears in 2 contracts
Samples: License Agreement (Synthorx, Inc.), License Agreement (Synthorx, Inc.)
Final Royalty Report. Upon termination or expiration of this Agreement, Licensee shall promptly submit a final report to TSRI, and any payments due to TSRI under this Agreement that accrued prior to such termination or expiration shall be paid by Licensee to TSRI at the time of delivery of the final report. [***] Certain information in this document has been omitted and unreimbursed patent expenses invoiced by TSRI shall become immediately payablefiled separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Samples: License Agreement (Corvus Pharmaceuticals, Inc.), License Agreement (Corvus Pharmaceuticals, Inc.)
Final Royalty Report. Upon termination or expiration of this Agreement, Licensee shall submit a final report to TSRI, TSRI and any payments due TSRI and unreimbursed patent expenses invoiced by TSRI shall become immediately payable.
Appears in 1 contract
Samples: License Agreement (Verastem, Inc.)
Final Royalty Report. Upon termination or expiration of this Agreement, Licensee shall submit a final report to TSRI, and any payments due TSRI and unreimbursed patent expenses invoiced incurred by TSRI prior to such expiration or termination pursuant to Section 8.3 shall become immediately payable.
Appears in 1 contract
